• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病(AD)患者的预期寿命。

Life expectancy in Alzheimer's disease (AD).

机构信息

UO Alzheimer-Memory Clinic, IRCCS Centra S. Giovanni di Dio Fatebenefratelli, Brescia, Italy.

出版信息

Arch Gerontol Geriatr. 2009;49 Suppl 1:237-43. doi: 10.1016/j.archger.2009.09.035.

DOI:10.1016/j.archger.2009.09.035
PMID:19836639
Abstract

Survival following a diagnosis of AD is important information for health planners, caregivers, patients, and their families. AD is associated with variable, but shortened life expectancy. Knowing the expected survival time may empower people with AD and their families, but clinicians currently have limited predictive information. A better knowledge about prognosis in patients affected by AD and related disorders should be of paramount importance in order to improve care plans and assist in medical decisions, above all for patients in the moderate-severe stages of the disease. Life expectancy for patients with AD can vary between 3 to 10 years. Many studies have tried to identify predictive factors that can be of help for clinicians. The main predictor of life expectancy is the age. Therefore caregivers, patients, and their families could plan on a median life span as long as 7 to 10 years for patients whose conditions are diagnosed when they are in their 60s and early 70s, to only about 3 years or less for patients whose conditions are diagnosed when they are in their 90s. Dementias with prominent psychiatric-behavioral manifestations and gait impairment have a faster progression compared to AD. However the many variables that influence life expectancy make difficult to define prognosis at the bedside and more studies are needed to assist clinicians in they daily routine with patients and caregivers.

摘要

AD 诊断后的生存情况是卫生规划者、护理人员、患者及其家属的重要信息。AD 与可变但缩短的预期寿命相关。了解预期的生存时间可能会赋予 AD 患者及其家属权力,但临床医生目前的预测信息有限。为了改善护理计划和协助医疗决策,特别是对于处于疾病中重度阶段的患者,更好地了解 AD 患者和相关疾病的预后应该至关重要。AD 患者的预期寿命可能在 3 至 10 年之间。许多研究都试图确定有助于临床医生的预测因素。预期寿命的主要预测因素是年龄。因此,对于在 60 多岁和 70 岁出头被诊断出患有这种疾病的患者,护理人员、患者及其家属可以计划一个中位数为 7 到 10 年的平均寿命,而对于在 90 多岁被诊断出患有这种疾病的患者,预期寿命可能只有 3 年或更短。与 AD 相比,具有明显精神行为表现和步态障碍的痴呆症进展更快。然而,影响预期寿命的许多变量使得难以在床边定义预后,需要更多的研究来帮助临床医生在日常工作中为患者和护理人员提供帮助。

相似文献

1
Life expectancy in Alzheimer's disease (AD).阿尔茨海默病(AD)患者的预期寿命。
Arch Gerontol Geriatr. 2009;49 Suppl 1:237-43. doi: 10.1016/j.archger.2009.09.035.
2
Prediction of survival in Alzheimer's disease--the LASER-AD longitudinal study.阿尔茨海默病患者生存预测——LASER-AD 纵向研究。
Int J Geriatr Psychiatry. 2009 Jul;24(7):739-47. doi: 10.1002/gps.2190.
3
Practical treatment strategies for patients with Alzheimer's disease.阿尔茨海默病患者的实用治疗策略。
J Fam Pract. 2007 Dec;56(12 Suppl New):S17-23.
4
Alzheimer's disease. AMA Council on Scientific Affairs Reference Committee D.阿尔茨海默病。美国医学协会科学事务委员会参考委员会D。
J Okla State Med Assoc. 1998 Aug;91(5):298-306.
5
A population-based retrospective cohort study comparing care for Western Australians with and without Alzheimer's disease in the last year of life.一项基于人群的回顾性队列研究,比较西澳大利亚州阿尔茨海默病患者和非阿尔茨海默病患者在生命最后一年的护理情况。
Health Soc Care Community. 2009 Feb;17(1):36-44. doi: 10.1111/j.1365-2524.2008.00795.x. Epub 2008 Jun 17.
6
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].[简短认知功能测试组合(B2C)的验证。在精神科实践中筛查阿尔茨海默病和抑郁症的价值]
Encephale. 2003 May-Jun;29(3 Pt 1):266-72.
7
Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.西班牙加那利群岛阿尔茨海默病的社会经济成本及生活质量
Neurology. 2006 Dec 26;67(12):2186-91. doi: 10.1212/01.wnl.0000249311.80411.93.
8
[Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].[阿尔茨海默病患者长期机构化的预测因素:照顾者负担的作用]
No To Shinkei. 2002 Sep;54(9):812-8.
9
Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.多奈哌齐在常规临床实践中对参加大型医疗保险管理式医疗计划的阿尔茨海默病及相关痴呆症患者医疗费用的影响:一项病例对照研究。
Am J Geriatr Pharmacother. 2005 Jun;3(2):92-102. doi: 10.1016/j.amjopharm.2005.07.001.
10
2009 Alzheimer's disease facts and figures.2009年阿尔茨海默病事实与数据。
Alzheimers Dement. 2009 May;5(3):234-70. doi: 10.1016/j.jalz.2009.03.001.

引用本文的文献

1
The longitudinal effects of global and regional brain measurements on cognitive abilities.全球和区域脑测量对认知能力的纵向影响。
Sci Rep. 2025 Jul 30;15(1):27846. doi: 10.1038/s41598-025-08152-6.
2
Natural Products and Their Neuroprotective Effects in Degenerative Brain Diseases: A Comprehensive Review.天然产物及其在退行性脑疾病中的神经保护作用:全面综述。
Int J Mol Sci. 2024 Oct 18;25(20):11223. doi: 10.3390/ijms252011223.
3
Transition of mild cognitive impairment to Alzheimer's disease: Medications as modifiable risk factors.
轻度认知障碍向阿尔茨海默病的转化:药物作为可改变的风险因素。
PLoS One. 2024 Aug 14;19(8):e0306270. doi: 10.1371/journal.pone.0306270. eCollection 2024.
4
Social Media Discourse Related to Caregiving for Older Adults Living With Alzheimer Disease and Related Dementias: Computational and Qualitative Study.社交媒体论谈及老年痴呆症和相关痴呆症患者的照护:计算与定性研究。
JMIR Aging. 2024 Jun 19;7:e59294. doi: 10.2196/59294.
5
Exploring Potential of Nano-formulations in the Treatment of Alzheimer's Disease through Nasal Route.探索纳米制剂经鼻途径治疗阿尔茨海默病的潜力。
Curr Alzheimer Res. 2024;21(10):693-709. doi: 10.2174/0115672050290462240222092303.
6
Deep Learning of Speech Data for Early Detection of Alzheimer's Disease in the Elderly.用于老年人阿尔茨海默病早期检测的语音数据深度学习
Bioengineering (Basel). 2023 Sep 18;10(9):1093. doi: 10.3390/bioengineering10091093.
7
Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment.了解阿尔茨海默病中的神经精神症状:诊断与治疗的挑战和进展
Front Neurosci. 2023 Sep 5;17:1263771. doi: 10.3389/fnins.2023.1263771. eCollection 2023.
8
Radiomics for Alzheimer's Disease: Fundamental Principles and Clinical Applications.阿尔茨海默病的放射组学:基本原理与临床应用。
Adv Exp Med Biol. 2023;1424:297-311. doi: 10.1007/978-3-031-31982-2_34.
9
Alzheimer's disease: a mini-review for the clinician.阿尔茨海默病:给临床医生的简短综述
Front Neurol. 2023 Jun 22;14:1178588. doi: 10.3389/fneur.2023.1178588. eCollection 2023.
10
Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease.死亡率在阿尔茨海默病疾病修饰治疗成本效益模型中的影响。
Alzheimers Dement (Amst). 2023 Mar 29;15(1):e12422. doi: 10.1002/dad2.12422. eCollection 2023 Jan-Mar.